Posts by: Iqra Mumal

News

A noninvasive method of detecting the presence of the SMN protein in blood samples may become the gold standard for evaluating and monitoring new therapeutic strategies for spinal muscular ... Read more

August 1, 2018August 10, 2018

Physical and Emotional Factors Weigh on SMA Patients’ Likelihood to Engage in Activities, Study Says

News

Degree of motor skills, and the intensity of feelings of depression and fatigue influence the degree to which adults with spinal muscular atrophy (SMA), regardless of subtype, participate in and ... Read more

July 23, 2018August 10, 2018

Motor Neuron Death in SMA Linked to Abnormal RNA Editing of 2 Proteins, Study Suggests

News

Motor neuron death in patients with spinal muscular atrophy is related to abnormal RNA editing of two specific proteins, which leads to the activation of a key cell death ... Read more

February 26, 2018July 6, 2018

Viral Footprint Could Increase Gene Therapy’s Efficiency for SMA, Other Diseases, Study Says

News

Scientists have discovered a new way to more efficiently deliver lower doses of gene therapies, and overcome adverse side effects that can be caused by high treatment dosages, a ... Read more

February 19, 2018February 20, 2018

Researchers Identify Ways to Measure SBMA Patients’ Swallowing Difficulties

News

Japanese researchers have identified ways to measure the swallowing difficulties of people with spinal and bulbar muscular atrophy, or SBMA. Two ways in particular could be useful in clinical trials, they ... Read more

January 29, 2018January 29, 2018

Scholar Rock, Outside Researchers Jointly Investigate Myostatin’s Role in SMA

News

Researchers have provided new insight into the activation process of myostatin, which is targeted by the antibody SRK-015 — a potential treatment for spinal muscular atrophy (SMA). The study, ... Read more

January 24, 2018January 24, 2018

NICE Asks Biogen to Submit Spinraza for STA on Path Toward Potential NHS Funding

News

The U.K’s National Institute for Health and Care Excellence (NICE) has formally invited Biogen to submit Spinraza (nusinersen) for Single Technology Appraisal (STA) on its course toward possible NHS funding. ... Read more

December 6, 2017December 6, 2017

Parents to SMA Children Ask Doctors to ‘Treat Us as Experts, Too’ in Swedish Study

News

Parents of children with spinal muscular atrophy (SMA) advise healthcare professionals to be more mindful of professional-family relations, improve and be willing to share their knowledge about SMA, and ... Read more

September 19, 2017September 19, 2017

Cure SMA to Host Webinar Today on Spinraza Access

News

Cure SMA will host a webinar on spinal muscular atrophy (SMA) today at 1 p.m. EST. The event focuses on access to Spinraza — the only U.S. government-approved therapy to treat ... Read more

August 31, 2017September 5, 2017

Molecule Shows Potential to Treat Mild Cases of SMA in Early Study

News

According to a new study, a molecule known as A15/283 being developed to treat SMA , has shown significant efficacy in male mouse models of the disease. A15/283 is a ... Read more

Posts by: Iqra Mumal

Iqra Mumal

Method of Detecting SMN Protein Could Be Used to Assess New SMA Therapies, Study Suggests

Motor Neuron Death in SMA Linked to Abnormal RNA Editing of 2 Proteins, Study Suggests

Viral Footprint Could Increase Gene Therapy’s Efficiency for SMA, Other Diseases, Study Says

Researchers Identify Ways to Measure SBMA Patients’ Swallowing Difficulties

Scholar Rock, Outside Researchers Jointly Investigate Myostatin’s Role in SMA

NICE Asks Biogen to Submit Spinraza for STA on Path Toward Potential NHS Funding

Parents to SMA Children Ask Doctors to ‘Treat Us as Experts, Too’ in Swedish Study

Cure SMA to Host Webinar Today on Spinraza Access

Molecule Shows Potential to Treat Mild Cases of SMA in Early Study

Pin It on Pinterest